Curaleaf Holdings (CURLF) Free Cash Flow (2019 - 2024)

Curaleaf Holdings (CURLF) posted quarterly Free Cash Flow of -$32.6 million for Q4 2024, up 13.96% year-on-year from -$28.6 million in Q1 2024, and down 146.52% on a QoQ basis from $70.2 million in Q3 2024.

Curaleaf Holdings (CURLF) Free Cash Flow (2019 - 2024) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Free Cash Flow for 6 consecutive years, with -$32.6 million the latest figure, recorded in Q4 2024.

  • Quarterly Free Cash Flow rose 13.96% year-over-year to -$32.6 million in Q4 2024, while the trailing twelve-month figure through Sep 2025 was -$32.6 million (down 130.98% YoY) and the FY2025 annual result came in at $134.9 million, down 9.09% from the prior year.
  • Free Cash Flow fell to -$32.6 million in Q4 2024 per CURLF's latest filing, from $70.2 million in the prior quarter.
  • Over the last five years, Free Cash Flow for CURLF reached as high as $43.8 billion in Q1 2024 and fell as low as -$43.7 billion in Q2 2024.
  • A 5-year average of $3.3 million and a median of $22.4 million in 2020 frame the typical range for Free Cash Flow.
  • Annual changes were most pronounced in 2020 — Free Cash Flow jumped 1404672.21% — and 2023, when it sank 21301.34%.
  • Year by year, Free Cash Flow stood at -$177.3 million in 2020, then surged by 113.4% to $23.8 million in 2021, then sank by 967.91% to -$206.2 million in 2022, then surged by 81.6% to -$37.9 million in 2023, then increased by 13.96% to -$32.6 million in 2024.
  • According to Business Quant data, Free Cash Flow over the past three periods registered -$32.6 million, $70.2 million, and -$43.7 billion for Q4 2024, Q3 2024, and Q2 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -208.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 291.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -373.37 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 363.70 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 348.40 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 144.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -38.00 Mn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 -32.64 Mn
Dec 31, 2024 -32.64 Mn
Sep 30, 2024 70.16 Mn
Sep 30, 2024 70.16 Mn
Jun 30, 2024 -43.70 Bn
Jun 30, 2024 -43.70 Bn
Mar 31, 2024 43.78 Bn
Mar 31, 2024 43.78 Bn
Dec 31, 2023 -37.94 Mn
Dec 31, 2023 -37.94 Mn
Sep 30, 2023 62.18 Mn
Sep 30, 2023 62.18 Mn
Jun 30, 2023 -7.88 Bn
Jun 30, 2023 -7.88 Bn
Mar 31, 2023 7.90 Bn
Mar 31, 2023 7.90 Bn
Dec 31, 2022 -206.21 Mn
Dec 31, 2022 -206.21 Mn
Sep 30, 2022 43.98 Mn
Sep 30, 2022 43.98 Mn